MAX Power Corporate Update as “MAXX” Makes Debut on CSE
VANCOUVER, British Columbia, Feb. 18, 2022 (GLOBE NEWSWIRE) — MAX Power Mining Corp. (“MAX Power” or the “Company”) is pleased […]
Rigetti Computing Names Retired General Peter Pace Chairman of the Board of Directors
Berkeley, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) — Rigetti Holdings, Inc. (“Rigetti Computing”), a pioneer in full-stack quantum computing, today […]
Verizon 5G Ultra Wideband and edge compute enable smart drones to navigate weather
What you need to know: Verizon brings 5G Ultra Wideband and mobile edge computing to the Caltech Center for Autonomous […]
Fancamp identifies possible mineralized 400 meters of unexplored copper and precious metal continuity between its Harvey Hill prospect and Foy occurrence: The Company Announces second drilling program for 2022
VANCOUVER, British Columbia, Feb. 03, 2022 (GLOBE NEWSWIRE) — Fancamp Exploration Ltd. (“Fancamp” or the “Corporation”) (TSX Venture Exchange: FNC) […]
BOSS Revolution Money Expands African Remittance Footprint
Money Transfers Now Available from the US to Togo, Sierra Leone, and Benin Newark, NJ., Feb. 03, 2022 (GLOBE NEWSWIRE) […]
STRONG/MDI and IMAX Produce the Tallest IMAX Screen in the World
JOLIETTE, Quebec, Feb. 03, 2022 (GLOBE NEWSWIRE) — STRONG/MDI Screen Systems, Inc. (“STRONG/MDI”) a wholly-owned subsidiary of Ballantyne Strong, Inc. […]
CPI Aerostructures Receives $1.9 Million Order for Welded Assemblies
EDGEWOOD, N.Y., Feb. 03, 2022 (GLOBE NEWSWIRE) — CPI Aerostructures, Inc. (“CPI Aero®”) (NYSE American: CVU) announced that it has […]
H&R Block named a ‘Best Place to Work for LGBTQ+ Equality’ for third consecutive year
KANSAS CITY, Mo., Feb. 03, 2022 (GLOBE NEWSWIRE) — H&R Block (NYSE: HRB) has been awarded the top score of […]
Acuity Brands unveils a new sustainability initiative, using technology to eliminate waste
Atlanta, GA, Feb. 03, 2022 (GLOBE NEWSWIRE) — Acuity Brands, Inc. (NYSE: AYI) (“Acuity or Company”), a market-leading industrial technology […]
Timber Pharmaceuticals Announces Positive End-of-Phase 2 Meeting with FDA for TMB-001 in Moderate to Severe Congenital Ichthyosis
– Full data from Phase 2b CONTROL study presented at 2022 Winter Clinical Dermatology Conference – – Company plans to […]
